Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Syneos Health® expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, continuing the momentum for Decentralized Solutions demonstrated by the recent acquisition of Illingworth ...
read more
Syndax and Nektar announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of NKTR-214 in combination with entinostat in patients with metastatic melanoma who have previously progressed on treatment with an anti-PD-1 ...
read more
Synairgen has announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 in COVID-19 patients has now been completed.
read more
Wednesday, November 07, 2018
Symphogen has selected TransPerfect’s Trial Interactive eTMF and supporting TMF services to centralize and streamline operations for current and future studies.
read more
Wednesday, October 08, 2025
Symeres has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities.
read more
Wednesday, January 14, 2026
Symeres announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a significant return to the company after a successful tenure as Senior Group Controller.
read more
Symeres has expanded its spray drying capabilities at its Cranbury, New Jersey, Chemistry, Manufacturing and Controls (CMC) development site to support formulation development for poorly soluble and development-challenged small molecule drug ...
read more
Symeres announced the appointment of Henning Steinhagen as Chief Executive Officer, marking a key transition as the company scales its operations and broadens its market reach.
read more
Symeres has partnered with Ambagon Therapeutics to explore a new class of small molecules, known as molecular glues, for potential use in colorectal cancer and other hard-to-target diseases.
read more
Wednesday, September 10, 2025
Symeres, a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate ...
read more
Tuesday, November 21, 2017
Symcel has secured a Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.
read more
Wednesday, December 21, 2016
Symcel, the provider of the cell-based assay tool for real-time cellular bioenergetic measurements, calScreener™, has partnered with Colzyx to test 25 different new collagen VI derived antimicrobial peptides – analyzing their capability to kill ...
read more
Monday, February 12, 2018
Symcel is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets.
read more
Wednesday, March 21, 2018
Symbiotix Biotherapies has entered into a license agreement with Harvard University.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more